Letter to the Editor: Response to Fitzgerald T et al. Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA
- Resource Type
- article
- Source
- Dermatology and Therapy, Vol 13, Iss 11, Pp 2911-2916 (2023)
- Subject
Claims data Clinical interpretation Methodology Persistence Psoriasis Dermatology RL1-803 - Language
- English
- ISSN
- 2193-8210
2190-9172